Skip to main content
. 2020 Oct 23;4(20):5157–5164. doi: 10.1182/bloodadvances.2020002452

Table 6.

ROTEM in patients with blood group O vs non-O

Blood group O (n = 136) Blood group non-O (n = 150) P BHC P* BHC*
Clotting time, mean (SD), s 671.5 (126.1) 637.4 (111.8) .016 <.05 .492 NS
Clot formation time, median (IQR), s 177.0 (149.5-216.5) 162.0(137.0-206.0) .043 NS .777 NS
Maximum clot firmness, mean (SD), mm 56.7 (5.0) 56.5 (5.6) .799 NS .014 <.05
Maximal lysis, mean (SD), % 13.3 (4.0) 15.0 (4.5) .001 <.05 .002 <.05
*

ANCOVA, adjusted for sex and VWF:Ag, VWF:RCo, and FVIII levels.

HHS Vulnerability Disclosure